Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-07-01 Sale | 2019-07-03 4:26 pm | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 951 | $2.35 | $2,235 | 63,524 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-01 Tax Withholding | 2024-04-03 5:06 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain CHIEF SCIENTIFIC OFFICER | 157 | $3.08 | 133,741 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:21 pm | N/A 2033-12-31 | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 62,500 | $0 | 196,398 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-03 5:21 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 157 | $2.28 | 196,398 (Direct) | View |
| 2023-12-13 Option Award | 2023-12-15 5:10 pm | N/A 2033-12-12 | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 62,500 | $0 | 134,055 (Direct) | View |
| 2023-10-02 Tax Withholding | 2023-10-04 4:23 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 1,184 | $3.83 | 9,055 (Direct) | View |
| 2023-06-30 Tax Withholding | 2023-07-05 4:34 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 151 | $4.1 | 10,239 (Direct) | View |
| 2023-03-31 Tax Withholding | 2023-04-04 5:05 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 480 | $3.08 | 10,390 (Direct) | View |
| 2022-12-31 Tax Withholding | 2023-01-04 5:09 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 1,720 | $0.15 | 220,252 (Direct) | View |
| 2022-09-30 Tax Withholding | 2022-10-04 5:05 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 1,719 | $0.223 | 221,972 (Direct) | View |
| 2022-06-30 Tax Withholding | 2022-07-05 5:01 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 1,719 | $0.389 | 223,691 (Direct) | View |
| 2022-03-31 Tax Withholding | 2022-04-04 5:09 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 3,469 | $0.65 | 225,410 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-18 5:10 pm | N/A 2032-03-17 | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 75,000 | $0 | 303,879 (Direct) | View |
| 2021-12-31 Tax Withholding | 2022-01-04 4:40 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 1,250 | $1.02 | 153,879 (Direct) | View |
| 2021-09-30 Tax Withholding | 2021-10-01 5:12 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 1,480 | $1.39 | 155,129 (Direct) | View |
| 2021-09-02 Option Award | 2021-09-03 5:34 pm | N/A 2031-09-02 | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 121,719 | $0 | 217,469 (Direct) | View |
| 2021-06-30 Tax Withholding | 2021-07-02 4:36 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 3,083 | $3.51 | 95,750 (Direct) | View |
| 2021-03-31 Tax Withholding | 2021-04-02 12:14 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 1,945 | $6.84 | 98,833 (Direct) | View |
| 2021-02-22 Option Award | 2021-02-24 4:39 pm | N/A 2031-02-22 | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 97,375 | $0 | 168,940 (Direct) | View |
| 2020-12-31 Tax Withholding | 2021-01-05 4:32 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 2,378 | $1.58 | 286,262 (Direct) | View |
| 2020-09-30 Tax Withholding | 2020-10-02 4:32 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer | 2,378 | $1.66 | 288,640 (Direct) | View |
| 2020-06-30 Tax Withholding | 2020-07-02 4:25 pm | N/A N/A | Menlo Therapeutics Inc. | MNLO | Stuart Iain Chief Scientific Officer | 2,378 | $1.73 | 291,018 (Direct) | View |
| 2020-05-06 Option Award | 2020-05-08 5:54 pm | N/A 2030-05-06 | Menlo Therapeutics Inc. | MNLO | Stuart Iain Chief Scientific Officer | 112,500 | $0 | 405,901 (Direct) | View |
| 2020-04-03 Option Award | 2020-04-07 5:22 pm | N/A N/A | Menlo Therapeutics Inc. | MNLO | Stuart Iain Chief Scientific Officer | 125,212 | $0 | 180,901 (Direct) | View |
| 2020-04-06 Tax Withholding | 2020-04-07 5:22 pm | N/A N/A | Menlo Therapeutics Inc. | MNLO | Stuart Iain Chief Scientific Officer | 3,763 | $1.4 | 180,901 (Direct) | View |
| 2020-03-31 Tax Withholding | 2020-04-02 4:41 pm | N/A N/A | Menlo Therapeutics Inc. | MNLO | Stuart Iain Chief Scientific Officer | 1,940 | $2.68 | 59,452 (Direct) | View |
| 2020-03-09 Option Award | 2020-03-11 5:57 pm | N/A 2026-11-15 | Menlo Therapeutics Inc. | MNLO | Stuart Iain Chief Scientific Officer | 212,667 | $0 | 212,667 (Direct) | View |
Ownership | 2020-03-11 5:53 pm | N/A N/A | Menlo Therapeutics Inc. | MNLO | Stuart Iain Chief Scientific Officer | 0 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:41 pm | N/A 2026-11-15 | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 358,998 | $0 | 0 (Direct) | View |
| 2020-02-24 Option Award | 2020-02-24 6:39 pm | N/A 2030-02-24 | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 137,664 | $0 | 200,001 (Direct) | View |
| 2019-12-31 Tax Withholding | 2020-01-03 5:23 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 514 | $3.28 | 62,337 (Direct) | View |
| 2019-09-30 Tax Withholding | 2019-10-02 4:20 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 673 | $3.07 | 62,851 (Direct) | View |